The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma...
The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis Conferences, aims to bring together researchers, scientists, industry leaders, and academicians from around the world to explore groundbreaking innovations in drug...
The DIA 2026 Global Annual Meeting is evolving, just like the life sciences community it serves. Join global innovators, regulators, academics, patient advocates, and industry leaders for an all-new experience designed to inspire, engage, and...
The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...
2nd Annual MaxPotent Pharma Summit – a leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active...
13th International Conference on Chemical and Biological Sciences (ICCBS 2026) will be held in Osaka, Japan during, co-sponsored by Network Joint Research Center for Materials and Devices: Dynamic Alliance for Open Innovation Bridging Human,...
energy, manufacturing, and sustainability, emphasizing its transformative impact on science and industry. World Nano 2026 will serve as a meeting point for thought leaders to exchange ideas, present research, and collaborate on innovative...
Conference on PharmScience Research & Development is scheduled to take place in Boston, MA from March 09 to 11, 2026. The 8th International Conference on PharmScience Research & Development is scheduled to take place in Boston, MA from March 09 to...
Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business. Meet Inspiring Speakers and Experts at our 3000+...
with savings of up to £379. Group discounts are also available. Discover the strategies driving pharma innovation in 2026.
relationships from within Japan and other regions of the world. We are pleased to invite and welcome you to attend 2026 16th International Conference on Bioscience, Biochemistry and Bioinformatics (ICBBB 2026) which will be held in Kobe, Japan...
supporting weight loss in people living with obesity. We are really looking forward to the commercial launch of MOVIVA® in 2026,” says Marcus Felstead, Chief Commercial Officer at Erbe Elektromedizin. Register for the free webinar "Advancing...
referencing Prolia and Xgeva. The products will be commercially available in Europe in December 2025 and January 2026, respectively. “We are very thrilled to launch OBODENCE and XBRYK through our direct sales efforts. Osteoporosis remains a major...
monitoring. KYZATREX will be available through multiple telehealth and traditional provider options in the first half of 2026.The availability of an oral testosterone option presents a convenient alternative to injectable or transdermal...
of BYOOVIZ upon the transfer of commercial rights from Biogen back to Samsung Bioepis, effective as of January 2026. “We are pleased to announce our direct commercialization initiative for BYOOVIZ in Europe. We will work closely with Biogen to...
candidate RLS-1496 in patients with actinic keratosis. The Gulf Cooperation Council (GCC) study is expected to begin in Q2 2026. “In our earliest meetings with the Hevolution team, we were convinced that Saudi Arabia and the GCC had the potential...
from development to delivery. The 20,000-square-foot expansion, which began in Q4 2025 and is expected to be finalized in 2026, will significantly strengthen Alcami's analytical capabilities in support of biologics, peptides, oligonucleotides,...
of CTx001. The trial will enrol patients across leading retinal centres with first patient dosing expected in the US in Q1 2026. The trial design is informed by data from i-GAIN, a natural history study involving over 230 participants, which has...
Waldencast plans to launch Obagi® saypha® MagIQ™ in the U.S. market alongside other important skin care innovations in 2026. This launch will leverage Obagi Medical’s established network of practices and aesthetic professionals, creating synergies...
potential in this patient population." The Company expects to report topline data from the Phase 3 CYPRESS trial in Q1 2026. In parallel, Theravance is preparing for an expedited NDA submission following the results and is planning to request...
